About
Discover the impact of cryopreservation of PBMCs on T cell activation and phenotype in Lonza’s free webinar.

Human peripheral blood mononuclear cells (PBMCs) consisting of lymphocytes, dendritic cells and monocytes play an important role in both innate and adaptive immune systems. As such, PBMCs are increasingly being used in the drug development of biological therapeutics. Should you be concerned how cryopreservation will affect the various sub-populations of immune cells contained in your PBMC sample or performance parameters of those cells? Are you looking for more convenience in your immunology research workflows? Lonza scientists investigated what possible effects cryopreservation could have on the functionality of PBMC samples.

Donec nec justo eget felis facilisis fermentum. Aliquam porttitor mauris sit amet orci. Aenean dignissim pellentesque felis.

In this webinar, you will learn about:
  • T cell proliferative response is not altered by cryopreservation

  • Cryopreservation does not change pro- or anti-inflammatory cytokines secretion profiles

  • Cryopreservation does not alter the percentages of cell populations in PBMCs

  • The data supports the more convenient use of cryopreserved PBMCs over freshly isolated cells
When
Tuesday, May 21, 2024 · 11:00 a.m. Eastern Time (US & Canada) (GMT -4:00)
Presenters
1712350218-d2ec635ba88247b2
Kevin Grady
Senior Market Development Manager, Lonza Cell Discovery
1712350760-7334816307dc83a5
Aurita Menezes, PhD
Senior Market Development Manager, Lonza Cell Discovery
Aurita Menezes, PhD is a Sr. market Development manager within the Marketing team at Lonza. In her role she is responsible for identifying products and product improvements that will serve the biologics and preclinical markets. Her portfolio focuses on hematopoietic immune and stem cells. She works closely with the Lonza R&D team to drive innovation with new primary cell products and assays. Aurita received her PhD in Microbiology and Immunology from University of Mississippi where she researched the major histocompatibility complex of Ictalurus punctatus. Previous to her role at Lonza she was a Sr. product manager at Integrated DNA technologies leading the development of qPCR gene expression and genotyping products
1712350832-666b5c7b12472fc7
Sarah Thacker, PhD
Former Principle Scientist, R&D Lonza Cell Discovery
1712350883-f25bef02fc125c9a
Katie Dunnick, PhD
MSAT Principal Process Engineer, Lonza
Katherine (Katie) Dunnick, PhD is a Principal Process Engineer within the MSAT team at Lonza where she focuses on process improvement projects. Prior to her work in MSAT, she was a member of the Lonza R&D team working on the development of new primary cell products and assays. Katie received her PhD in Pharmaceutical and Pharmacological Sciences from West Virginia University where she researched the effects of nanoparticles on pulmonary systems, both in vitro and in vivo. After completing her PhD, she joined ScitoVation where she developed a novel assay to detect double strand DNA breaks via flow cytometry. She then joined MatTek as a Business Development/Marketing Manager prior to joining the Lonza MSAT team.
Reserve Your Spot
First Name*
Last Name*
Email Address*
Organization / Company*
Country / Region*
Area of Work:*
Job Function:*
utm_bmcr_source
Registration Terms
This event is hosted by the Scientist.com family of companies. Specific brands and sites associated with this event include InsideScientific. By registering and participating, you acknowledge that your personal data will be processed by the webinar platform (BigMarker) and Scientist.com. You also agree to receive email communication from InsideScientific about this webinar and other programs of similar nature. The sponsor of this webinar is Lonza; by registering and participating, you acknowledge that your data will be processed in accordance with Lonza's Privacy Policy. You will receive email communication from Lonza about this webinar and programs of similar interest. You can withdraw your consent at any time from these communications.
Yes, I consent to the registration terms.*
Yes, I consent to the registration terms.*
We use BigMarker as our webinar platform. By clicking Register, you acknowledge that the information you provide will be transferred to BigMarker processing in accordance with their Terms of Service and Privacy Policy.